Digoxin use and the risk for colorectal cancer

Nov-14

AUTHORS : Dr Yu-Xiao Yang, MD, MSCE, Department of Medicine, University of Pennsylvania Perelman School of Medicine, 423 Guardian Drive, 733 Blockley Hall, Philadelphia, Pennsylvania 19010, USA – Email: yangy@pennmedicine.upenn.edu / yangy@mail.med.upenn.edu – Profile: https://www.med.upenn.edu/apps/faculty/index.php/g275/p18504

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 23(11):1147-53

DOI : 10.1002/pds.3717

Digoxin use and the risk for colorectal cancer

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study